From Code to Cure®
Compugen (cgen.com) scores 82 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, Technology brands, in the 79th percentile of 8133 Healthcare brands.
Compugen is a publicly traded, Israeli clinical-stage drug discovery and development company headquartered in Holon, founded in 1993. It uses its proprietary Unigen platform, which combines computational biology with AI/ML, to identify novel drug targets and biological pathways, with a focus on developing first-in-class cancer immunotherapies. The company works at the intersection of computational discovery and immuno-oncology to advance novel therapeutic candidates toward clinical development.
| Brand Name | Compugen |
|---|---|
| Domain | cgen.com |
| Industry | Healthcare, Technology |
| Founded | 1993 |
| Headquarters | Holon |
| Main Competitors | Exscientia (80/100), BenevolentAI (74/100), Insilico Medicine (83/100), Recursion Pharmaceuticals (85/100), Schrödinger (87/100), Immunocore, Nimbus Therapeutics |
Moz Domain Authority 48/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Compugen a clinical-stage drug discovery and development company utilizing predictive computational discovery platform to identify novel drug targets and new biological pathways an…" (Meta description: 27 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, X (Twitter), Facebook, Instagram, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Compugen?", Claude could identify the brand as of September 2026. Compugen is an Israeli clinical-stage biotherapeutics company that uses computational biology and predictive discovery platforms to identify novel drug targets, with a focus on immuno-oncology. Best known for Its computational target discovery platform used to identify novel immuno-oncology drug candidates like COM701 and COM902.
When asked "Best brands similar to Compugen?", Claude would recommend Compugen as of September 2026. It's a notable player in computational drug discovery and immuno-oncology, so it could come up alongside other biotech platform companies in that niche.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Compugen's main competitors in Healthcare: Exscientia (80/100), BenevolentAI (74/100), Insilico Medicine (83/100), Recursion Pharmaceuticals (85/100), Schrödinger (87/100).
Sources: Brand Analyzer scan
Compugen's core offering is its Unigen platform, a predictive computational discovery system that identifies novel drug targets and biological pathways. Using this platform, the company develops cancer immunotherapy drug candidates, positioning itself as a clinical-stage biotechnology company rather than a seller of commercial products.
Sources: Compugen official site
Compugen is a publicly traded, Israeli clinical-stage drug discovery and development company headquartered in Holon, founded in 1993. It specializes in computational biology-driven discovery of novel drug targets, particularly for cancer immunotherapy.
Sources: Compugen official site
Compugen has limited AI-search visibility, scoring 34/100 on Brand Analyzer's AI visibility composite (visibility 23, trust 43, recommendation 43). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Compugen official site
Compugen was founded in 1993. Compugen operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Compugen is headquartered in Holon. Compugen operates in the Healthcare category.
Sources: Wikidata
Compugen scores 43/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Compugen official site
Compugen is known for its Unigen predictive computational discovery platform, which combines deep scientific knowledge with AI/ML innovation to identify novel immuno-oncology drug targets and biological pathways that traditional discovery methods may overlook.
Sources: Compugen official site
Compugen can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Compugen official site
Compugen's platform and discoveries are used internally to develop its own immuno-oncology drug candidates, and the company engages with pharmaceutical and biotech partners, investors, oncology researchers, and clinicians interested in computationally-derived cancer immunotherapy candidates.
Sources: Compugen official site
Compugen scores 34/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Compugen has a weak AI-visibility profile at 34/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is trust (43/100) and its weakest is visibility (23/100). It benefits from a Wikidata knowledge-graph entry, a Moz Domain Authority of 48/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Compugen from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Compugen: CENTOGENE (82/100), Centivo (82/100), CompuGroup Medical (82/100), Charlotte's Web (82/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.